Clinical capacity Paratus operates a high-complexity CLIA certified laboratory with nationwide testing capabilities and a focus on time-sensitive diagnostic solutions, presenting an opportunity to discuss expanded validation services, contract testing, and scalable throughput partnerships for high-demand panels.

Point-of-care focus The company’s goal to deliver lab-quality results at the point of care via integrated molecular, biochemical, microfluidic, and optics technologies suggests openings for collaborations on portable diagnostic devices, field deployable testing kits, and OEM partnerships.

Saliva diagnostics Emphasis on accurate, efficient, patient-friendly salivary tests opens doors for sales conversations around non-invasive sampling solutions, peripheral devices, and associated supply chains for saliva collection and processing hardware.

Award and growth signal Innovation Award in 2017 and ongoing funding indicate a credibility boost and potential interest in strategic partnerships, grants, or consortium opportunities to co-develop next-generation diagnostics or scale up manufacturing.

Early-stage traction Revenue is modest and funding is non-dilutive, highlighting a need for capacity building, manufacturing outsourcing, or clinical trial collaborations to accelerate commercialization, field trials, and revenue growth with healthcare providers and biotech partners.